Does DEGARELIX Cause Prostate cancer? 87 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Prostate cancer have been filed in association with DEGARELIX (FIRMAGON). This represents 2.3% of all adverse event reports for DEGARELIX.
87
Reports of Prostate cancer with DEGARELIX
2.3%
of all DEGARELIX reports
52
Deaths
37
Hospitalizations
How Dangerous Is Prostate cancer From DEGARELIX?
Of the 87 reports, 52 (59.8%) resulted in death, 37 (42.5%) required hospitalization, and 2 (2.3%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
Yes, Prostate cancer is listed as a known adverse reaction in the official FDA drug label for DEGARELIX.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
Which DEGARELIX Alternatives Have Lower Prostate cancer Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM